S. Advani, S. Pai, D. Venzon, M. Adde, P. K. Kurkure, C. N. Nair, B. Sirohi, S. D. Banavali, R. Hawaldar, B. B. Kolhatkar, T. Vats and I. Magarth, “Acute Lymphoblastic Leukemia in India: An Analysis of Prognostic Factors Using a Single Treatment Regimen,” Annals of Oncology, Vol. 10, No. 2, 1999, pp. 167-176. doi:10.1023/A:1008366814109

has been cited by the following article:

• TITLE: Post-Therapy Profile of BMI-for-Age of Indian Survivors of Pediatric Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

  AUTHORS: Chanda D. Gokhale, Shobha A. Udipi, Ramakrishna Y. Ambaye, Suresh K. Pai, Suresh H. Advani

  KEYWORDS: Body Mass Index; Children; Indian; Acute Lymphoblastic Leukemia; Non-Hodgkin’s Lymphoma

  JOURNAL NAME: Food and Nutrition Sciences, Vol.3 No.10, October 12, 2012

  ABSTRACT: Background: Obesity in pediatric ALL survivors is a well recognized late effect. Hence the present study examines the BMI-for-age of Indian childhood ALL and NHL survivors. Method: A retrospective study of 118 ALL/NHL survivors and 138 age sex matched was carried out. From the recorded heights and weights were body mass index (BMI) was computed. The survivor data was compared with 138 controls from the data set collected by investigators previously. Results: 82.8% of patients had BMI-for-age in 5th-84th percentile (healthy) at time of diagnosis and at inclusion in the study. Comparison of BMI of survivors with matched controls was not significant. However, The mean BMI-for-age for younger patients (3 to 12 years) was significantly higher than mean BMI-for-age of matched controls. Distribution of data by time elapsed from therapy was significant. Overweight/obesity was observed among the survivors who were off therapy for two years with increase in after four years post-therapy. Conclusion: Our preliminary study indicates late effects of therapy and points to the need of long term assessment of the survivors, even though majority of them were within the normal weight range.